Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Paragon non-exec invests, CentralNic board member linked to sale

(Sharecast News) - Paragon Banking Group was among those on the list of buys on Wednesday, after a non-executive director and their associated invested in shares. The FTSE 250 company said Tanvi Davda purchased 3,936 shares on 10 July, in a single transaction on the London Stock Exchange.

At the same time, Reya Harris - a "person closely associated" with Davda - picked up 1,765 shares in the company.

In its disclosure, Paragon said Davda paid 505.495p for each of the 3,936 shares purchased, while Harris paid 506.94p apiece.

On the selling side of the ledger was CentralNic, after a company linked to a non-executive director sold around 2.4 million shares.

The firm said Inter.services sold 205,364 shares on 5 July for 115p each, before selling 2,196.636 shares on 7 July for 114.8p apiece.

Both transactions took place on the AIM market of the London Stock Exchange.

CentralNic said Inter.services is a company associated with its non-executive director Horst Saffron.

As a result of the transactions, it said Sifting's beneficial interest in CentralNic now totalled 32,000,000 shares, held entirely through Inter.services.

At 1437 BST, shares in Paragon Banking Group were up 3.09% at 517p, while those in CentralNic were 1.72% firmer at 124.71p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Paragon Banking Group (PAG) Director name: Davda,Tanvi Amount purchased: 3,936 @ 505.50p Value: �19,896.28

Roquefort Therapeutics (ROQ) Director name: West,Stephen Paul Amount purchased: 143,390 @ 6.24p Value: �8,947.54

Paragon Banking Group (PAG) Director name: Davda,Tanvi Amount purchased: 1,765 @ 506.94p Value: �8,947.49

Reneuron Group (RENE) Director name: Hawkins,John Amount purchased: 52,332 @ 8.95p Value: �4,683.19

Calnex Solutions (CLX) Director name: Greenan,Ashleigh Joanne Amount purchased: 1,565 @ 115.00p Value: �1,799.75

Spiritus Mundi (SPMU) Director name: Metcalfe,Tim Amount purchased: 29,239 @ 3.42p Value: �999.97

Spiritus Mundi (SPMU) Director name: Metcalfe,Tim Amount purchased: 35,460 @ 2.82p Value: �999.97

Roquefort Therapeutics (ROQ) Director name: West,Stephen Paul Amount purchased: 15,730 @ 6.25p Value: �983.13

Prudential (PRU) Director name: Bulmer ,Ben Amount purchased: 38 @ 1,033.97p Value: �392.91

Zotefoams (ZTF) Director name: McGrath ,Gary Amount purchased: 45 @ 338.00p Value: �152.10

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 860 @ 17.45p Value: �150.07

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 860 @ 17.45p Value: �150.07

Zotefoams (ZTF) Director name: Stirling,David Amount purchased: 44 @ 338.00p Value: �148.72

Top Director Sells

Centralnic Group (CNIC) Director name: Siffrin,Alexander Oskar Amount sold: 2,196,636 @ 114.80p Value: �2,521,738.13

Centralnic Group (CNIC) Director name: Siffrin,Alexander Oskar Amount sold: 203,364 @ 115.00p Value: �233,868.60

Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 44,994 @ 27.10p Value: �12,193.37

Staffline Group (STAF) Director name: Spain,Thomas Amount sold: 8,080 @ 27.10p Value: �2,189.68

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.